Published in J Gastrointest Surg on May 06, 2009
Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion. Medicine (Baltimore) (2015) 1.88
Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization. PLoS One (2013) 1.63
Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection? Medicine (Baltimore) (2014) 1.02
Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg (2012) 1.02
Therapeutic options for intermediate-advanced hepatocellular carcinoma. World J Gastroenterol (2011) 1.00
Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations. World J Gastroenterol (2014) 0.96
Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated? World J Gastroenterol (2011) 0.94
Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives. World J Hepatol (2015) 0.91
Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World J Hepatol (2015) 0.89
Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC. Int J Hepatol (2011) 0.82
Percutaneous radiofrequency ablation versus partial hepatectomy for multicentric small hepatocellular carcinomas: a nonrandomized comparative study. World J Surg (2010) 0.82
Is there any benefit from expanding the criteria for the resection of hepatocellular carcinoma in cirrhotic liver? Experience from a developing country. World J Surg (2012) 0.80
Outcomes of surgical resection and loco-regional therapy in patients with stage 3A hepatocellular carcinoma: a retrospective review from the national cancer database. HPB (Oxford) (2015) 0.78
Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma. BMC Surg (2016) 0.76
From minimal to maximal surgery in the treatment of hepatocarcinoma: A review. World J Hepatol (2015) 0.76
Controversies and evidence of hepatic resection for hepatocellular carcinoma. BBA Clin (2016) 0.76
Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System. Medicine (Baltimore) (2015) 0.75
What we learned from difficult hepatectomies in patients with advanced hepatic malignancy. Korean J Hepatobiliary Pancreat Surg (2011) 0.75
Role of liver resection in the management of multinodular hepatocellular carcinoma. World J Hepatol (2015) 0.75
Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response. Am J Gastroenterol (2007) 1.93
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg (2009) 1.84
Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg (2013) 1.83
Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation. World J Gastroenterol (2004) 1.81
Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg (2004) 1.65
Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. J Clin Endocrinol Metab (2013) 1.59
Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol (2009) 1.56
Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg (2012) 1.34
Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients. Arch Surg (2012) 1.33
Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg (2007) 1.32
Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. Eur J Radiol (2012) 1.18
Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol (2006) 1.17
How much remnant is enough in liver resection? Dig Surg (2012) 1.14
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups. Oncotarget (2014) 1.14
Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection. Ann Surg Oncol (2011) 1.13
Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J (2007) 1.13
Drug-induced anti-factor VIII antibodies: a systematic review. Med Sci Monit (2007) 1.06
Safety and feasibility of Irreversible Electroporation (IRE) in patients with locally advanced pancreatic cancer: results of a prospective study. Dig Surg (2015) 1.05
Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. J Hepatol (2013) 1.04
Nodal abdominal spread in adenocarcinoma of the cardia. Results of a multicenter prospective study. Gastric Cancer (1998) 0.99
Gastroduodenal artery stump haemorrhage following pylorus-sparing Whipple procedure: treatment with covered stents. Dig Surg (2002) 0.98
Aggressive approach to acinar cell carcinoma of the pancreas: a single-institution experience and a literature review. Langenbecks Arch Surg (2010) 0.98
The effect of iron depletion on chronic hepatitis C virus infection. Hepatol Int (2008) 0.96
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. Am J Surg (2011) 0.95
Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated? World J Gastroenterol (2011) 0.94
Acoustic radiation force impulse of the liver. World J Gastroenterol (2013) 0.91
Focal pancreatic lesions: accuracy and complications of US-guided fine-needle aspiration cytology. Abdom Imaging (2009) 0.90
Ultrasound-guided percutaneous fine-needle aspiration of 545 focal pancreatic lesions. AJR Am J Roentgenol (2009) 0.89
The Dagradi-Serio-Iacono operation central pancreatectomy. J Gastrointest Surg (2007) 0.89
Treatment of type II endoleaks after endovascular repair of abdominal aortic aneurysms: transcaval approach. Cardiovasc Intervent Radiol (2005) 0.89
Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J Gastrointest Surg (2007) 0.89
Liver resection for hepatocellular carcinoma ≤3 cm: results of an Italian multicenter study on 588 patients. J Am Coll Surg (2012) 0.89
Comparison of the prognostic accuracy of the sixth and seventh editions of the TNM classification for intrahepatic cholangiocarcinoma. HPB (Oxford) (2011) 0.88
Contrast-enhanced ultrasonography of the pancreas. Pancreatology (2009) 0.88
Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study. Anticancer Res (2007) 0.88
Perigastric lymph node metastases in gastric cancer: comparison of different staging systems. Gastric Cancer (1999) 0.87
Usefulness of contrast-enhanced intraoperative ultrasonography (CE-IOUS) in patients with colorectal liver metastases after preoperative chemotherapy. J Gastrointest Surg (2012) 0.86
Behavior of hepatocellular adenoma on real-time low-mechanical index contrast-enhanced ultrasonography with a second-generation contrast agent. J Ultrasound Med (2008) 0.86
Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? J Surg Oncol (2010) 0.86
Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. J Gastrointest Surg (2013) 0.86
The influence of aminotransferase levels on liver stiffness assessed by Acoustic Radiation Force Impulse Elastography: a retrospective multicentre study. Dig Liver Dis (2013) 0.85
Diagnostic value of hepatocellular nodule vascularity after microbubble injection for characterizing malignancy in patients with cirrhosis. AJR Am J Roentgenol (2007) 0.85
Tumor vessel compression hinders perfusion of ultrasonographic contrast agents. Neoplasia (2005) 0.85
Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study. J Gastrointest Surg (2011) 0.84
Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. Dig Liver Dis (2012) 0.83
Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study. Eur J Gastroenterol Hepatol (2010) 0.83
Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study. World J Gastroenterol (2005) 0.83
Case report: appearance of an intestinal metastasis from intrahepatic cholangiocarcinoma occurring 5 years after resection of the primary tumor. Eur J Gastroenterol Hepatol (2010) 0.83
Clinicopathological features of adenosquamous pancreatic cancer. Langenbecks Arch Surg (2010) 0.83
Ultrasonography of the pancreas. Radiol Clin North Am (2012) 0.83
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. PLoS One (2013) 0.82
Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors. AJR Am J Roentgenol (2009) 0.82
Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma. HPB (Oxford) (2011) 0.82
Management of nodal disease from colon cancer in the laparoscopic era. Int J Colorectal Dis (2014) 0.81
Treatment of hepatitis C in hemophiliacs. Am J Hematol (2006) 0.81
Intra-arterial infusion of 5-fluorouracil, leucovorin, epirubicin and carboplatin (FLEC regimen) in unresectable pancreatic cancer: results of a ten-year experience. In Vivo (2007) 0.81
Fibromuscular dysplasia: noninvasive evaluation of unusual case of renal and mesenteric involvement. Urology (2008) 0.81
Is routine imaging necessary after pancreatic resection? An appraisal of postoperative ultrasonography for the detection of pancreatic fistula. Pancreas (2014) 0.80
In vivo mapping of spontaneous mammary tumors in transgenic mice using MRI and ultrasonography. J Magn Reson Imaging (2004) 0.80
Prognostic factors in patients with advanced pancreatic adenocarcinoma treated with intra-arterial chemotherapy. Pancreas (2008) 0.80
A rare case of incidental pancreatic arteriovenous malformation correctly diagnosed with MDCT. JOP (2013) 0.80
Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma. Cancer Chemother Pharmacol (2006) 0.80
Pancreatic Neuroendocrine Neoplasms: Clinical Value of Diffusion-Weighted Imaging. Neuroendocrinology (2015) 0.80
Liver abscess due to acute cholecystitis. Report of five cases. Chir Ital (2003) 0.79
Surgical treatment of gastric cancer with coexistent abdominal aortic aneurysm. Personal experience and literature review. Hepatogastroenterology (2006) 0.79
Update on chronic hepatitis C in hemophiliacs. Haematologica (2002) 0.78
Acoustic radiation force impulse ultrasound imaging of pancreatic cystic lesions: preliminary results. Pancreas (2010) 0.78
Non-traumatic abdominal emergencies: imaging and intervention in acute pancreatic conditions. Eur Radiol (2002) 0.78
Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography. Pancreas (2008) 0.77